Cargando…
Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial
Objective To determine the efficacy of a 23-valent pneumococcal polysaccharide vaccine in people at high risk of pneumococcal pneumonia. Design Prospective, randomised, placebo controlled double blind study. Setting Nursing homes in Japan. Participants 1006 nursing home residents. Interventions Part...
Autores principales: | Maruyama, Takaya, Taguchi, Osamu, Niederman, Michael S, Morser, John, Kobayashi, Hiroyasu, Kobayashi, Tetsu, D’Alessandro-Gabazza, Corina, Nakayama, Sei, Nishikubo, Kimiaki, Noguchi, Takashi, Takei, Yoshiyuki, Gabazza, Esteban C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834887/ https://www.ncbi.nlm.nih.gov/pubmed/20211953 http://dx.doi.org/10.1136/bmj.c1004 |
Ejemplares similares
-
No Strong Evidence for Ruling Out the Role of Coagulation in Long-Term Disability after Critical Illness
por: Yasuma, Taro, et al.
Publicado: (2021) -
Too Premature to Deny the Potential of Thrombomodulin Alfa in Idiopathic Pulmonary Fibrosis
por: Kobayashi, Tetsu, et al.
Publicado: (2020) -
Efficacy of osimertinib in a patient with non-small cell lung cancer harboring epithelial growth factor receptor exon 19 deletion/T790M mutation, with poor performance status
por: Nishii, Yoichi, et al.
Publicado: (2018) -
Response of Lung Microbiota to Changes of Pulmonary Innate Immunity under Healthy Conditions
por: Yasuma, Taro, et al.
Publicado: (2021) -
The Need for a CYFRA 21-1 Cutoff Value to Predict Clinical Progression of IPF in Clinical Practice
por: Fujimoto, Hajime, et al.
Publicado: (2022)